Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 19 most recent Form 4 transactions.
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 32,976 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 30,146 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 30,476 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 45,095 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 22,087 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 30,146 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 30,146 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 15,073 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | AGRANT | 15,073 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 127,804 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jan 28 | APLS | Apellis Pharmaceuticals,… | AGRANT | 30,146 | — | — | +30.9% | Open the original filing on SEC.gov |
| Sep 2, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 45,766 | — | — | — | Open the original filing on SEC.gov |
| Sep 2, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT | 30,476 | — | — | +45.4% | Open the original filing on SEC.gov |
| Jun 9, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 67,396 | $19.39 | $1.3M | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT | 45,095 | — | — | +204.2% | Open the original filing on SEC.gov |
| May 28, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 32,976 | $16.80 | $554K | — | Open the original filing on SEC.gov |
| May 28, 2025 | APLS | Apellis Pharmaceuticals,… | AGRANT | 22,087 | — | — | — | Open the original filing on SEC.gov |